Loading...

226 posters, 5 topics, 20 sessions, 599 authors, 292 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Obstetric Anaesthesia Annual Scientific Meeting 2026

14-15 May 2026 | Liverpool Convention Centre

Obstetric Anaesthesia Annual Scientific Meeting 2026 banner

7162503

Noradrenaline for neuraxial anaesthesia--induced hypotension in severe peripartum cardiomyopathy

Part of Topic

Case report

Vasopressor Choice in Neuraxial Anaesthesia for Caesarean Delivery in Severe Left Ventricular Dysfunction: A Case Report

Background

Hypotension following neuraxial anaesthesia is common and typically managed with phenylephrine. In patients with severely reduced left ventricular ejection fraction (LVEF), pure α-agonists may:
• Increase afterload

• Reduce cardiac output
• Trigger reflex bradycardia
• Worsen haemodynamic instability
Noradrenaline provides
α-vasoconstriction with modest β1 inotropy, potentially offering a more favourable profile in cardiac disease. (Fig 1)

Dr I E Roberts, Dr D Leslie, University Hospital of Wales

Vasopressor Response

Following neuraxial block, the patient developed significant hypotension. Phenylephrine (first-line)
• Initiated as per standard obstetric practice
• Failed to maintain MAP ≥65 mmHg

• Concern for reduced cardiac output due to reflex bradycardia and increased afterload

Switch to Noradrenaline (16mcg/ml) (Alpha v Beta) • MAP stabilised between 65–80 mmHg
• HR maintained at 90–100 bpm
• Oxygen saturation remained ≥99%

• Marked improvement in haemodynamic stability
Estimated blood loss:
933 mL Delivery was uncomplicated; neonate well.

Postoperative Course

• Epidural retained for 24 hours for analgesia (Morphine allergy) • Continued diuresis and cardiac optimisation
• Persistent LV dysfunction postpartum (EF 34–35%)
• No further hypotensive episodes

• Ongoing heart failure therapy and cardiology follow-up

Discussion

Haemodynamic physiology & vasopressor choice

  • Neuraxial anaesthesia → ↓SVR and preload

  • Healthy parturients maintain CO via ↑HR and stroke volume

  • In severe LV dysfunction, compensation is limited → vasopressor

choice critical

Why phenylephrine underperforms

  • Pure α1-agonist → ↑afterload

  • Dilated LV → ↓stroke volume

  • Reflex bradycardia → ↓CO (Fig 2 and 3)

  • May worsen perfusion

  • Observed in this case: inadequate

    MAP despite escalation

    Why noradrenaline is preferable

    • α1 vasoconstriction restores MAP
    • β1 effect supports contractility and HR
    • Better CO preservation
    • Less reflex bradycardia
    • Evidence: ↑CO, more stable HR, similar

    foetal outcomes (Fig 2 and 3)

    Clinical implications

    • Individualise vasopressor choice in cardiac disease

    • Avoid phenylephrine in severe LV dysfunction

    • Noradrenaline provides balanced haemodynamics

Fig 2. Vasopressor response in Normal heart

Case Summary

Peripartum Cardiomyopathy with Superimposed Pre-eclampsia

Presentation: 37yo G3P0, 36+2 Weeks (BMI 57)
•Symptoms: Severe dyspnea, orthopnea, peripheral edema. •Signs: Tachycardia (140–170 bpm), BP 146/100, Proteinuria 3+. Diagnostics
•Echo: Dilated LV; LVEF ~35%.
•NT-proBNP: 1348 ng/L.
•Diagnosis: PPCM with superimposed pre-eclampsia.

Management
•Critical Care: Diuretics, antihypertensives, MgSO4, anticoagulation. •Delivery: Planned within 12–24 hours.

Anaesthetic Technique

A combined spinal–epidural (CSE):
• Spinal: 1 mL 0.5% hyperbaric bupivacaine + fentanyl + morphine • Epidural: Incremental levobupivacaine
• Arterial line inserted pre-operatively
• Difficult spinal (3 attempts)
Caesarean delivery proceeded under CSE.

oaa2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.